Immersive Therapeutics
AI-personalisedimmersivetherapeutics
Personalised therapeutic media, augmented reality and therapeutic scent — developed through a clinician-led process to create sensory-rich therapeutic experiences.
Immersive Therapeutics is developing AI-Personalised Immersive Therapy (AI-PIT): using AI as a production technology to transform clinician-directed therapeutic material into highly personalised audiovisual and multisensory experiences.
Currently being developed and evaluated within the TMS Plus model of personalised interventional mental healthcare.
AI-PIT
Creating personalised therapeutic experiences
AI-Personalised Therapeutic Media
Clinician-directed audiovisual experiences personalised around therapeutic goals, memories, environments, emotional associations and meaningful life experiences.
Augmented Reality
Extending personalised therapeutic experiences into the treatment environment through AR-based immersion.
Therapeutic Scent
Programmable olfactory stimulation designed to add another sensory dimension to personalised therapeutic experiences.
AI-PIT interventions
Different therapeutic purposes
AI-ERP Exposure and Response Prevention
Personalised exposure experiences designed to help individuals practise tolerating uncertainty and resisting compulsive responses.
Read more on MindSkiller →AI-BEAT Behavioural and Emotional Activation
Personalised experiences drawing upon meaningful memories, people, places, interests, values and future goals to support motivation, behavioural activation and positive emotional engagement.
Read more on MindSkiller →AI-REFLECT Reflective Therapy
Personalised reflective experiences supporting self-understanding, therapeutic integration and consolidation of progress.
Read more on MindSkiller →
Our approach
Clinician-led. AI-enabled. Personally meaningful.
AI does not diagnose the patient or independently determine treatment.
The clinician determines the formulation, therapeutic objective and boundaries of the intervention.
AI is used as a production technology to transform clinician-directed therapeutic material into personalised audiovisual and multisensory experiences.
